Author: Alizadeh, Seyedeh Roya; Hashemi, Seyedeh Mahdieh
Title: Development and therapeutic potential of 2-aminothiazole derivatives in anticancer drug discovery Cord-id: qwpx12ty Document date: 2021_1_15
ID: qwpx12ty
Snippet: Currently, the development of anticancer drug resistance is significantly restricted the clinical efficacy of the most commonly prescribed anticancer drug. Malignant disease is widely prevalent and considered to be the major challenges of this century, which concerns the medical community all over the world. Consequently, investigating small molecule antitumor agents, which could decrease drug resistance and reduce unpleasant side effect is more desirable. 2-aminothiazole scaffold has emerged as
Document: Currently, the development of anticancer drug resistance is significantly restricted the clinical efficacy of the most commonly prescribed anticancer drug. Malignant disease is widely prevalent and considered to be the major challenges of this century, which concerns the medical community all over the world. Consequently, investigating small molecule antitumor agents, which could decrease drug resistance and reduce unpleasant side effect is more desirable. 2-aminothiazole scaffold has emerged as a promising scaffold in medicinal chemistry and drug discovery research. This nucleus is a fundamental part of some clinically applied anticancer drugs such as dasatinib and alpelisib. Literature survey documented that different 2-aminothiazole analogs exhibited their potent and selective nanomolar inhibitory activity against a wide range of human cancerous cell lines such as breast, leukemia, lung, colon, CNS, melanoma, ovarian, renal, and prostate. In this paper, we have reviewed the progresses and structural modification of 2-aminothiazole to pursuit potent anticancers and also highlighted in vitro activities and in silico studies. The information will useful for future innovation. [Figure: see text]
Search related documents:
Co phrase search for related documents- active compound and low cytotoxicity: 1, 2
- active compound and low toxicity: 1
- active compound and lung adenocarcinoma: 1
- active compound and lung cancer: 1, 2, 3
- active compound and lung cancer cell: 1, 2, 3
- active compound and lung cancer cell line: 1, 2, 3
- active compound and lung carcinoma: 1
- active site and additional interaction: 1
- active site and adme prediction: 1
- active site and adme property: 1
- active site and liver cancer: 1
- active site and low cytotoxicity: 1, 2
- active site and low micromolar: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- active site and low nanomolar range: 1, 2
- active site and low potency: 1, 2, 3, 4, 5
- active site and low toxicity: 1, 2
- active site and lung adenocarcinoma: 1, 2
- active site and lung cancer: 1
- active site and lung carcinoma: 1
Co phrase search for related documents, hyperlinks ordered by date